Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)(1B/D) receptor agonist zolmitriptan (311C90): Are brain stem sites therapeutic target in migraine?

Pain

Volumn 67, Issue 2-3, 1996, Pages 355-359

  Goadsby, Peter J ^a,b   Hoskin, Karen L ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

migraine; trigeminal nucleus; zolmitriptan

Indexed keywords

SUMATRIPTAN; ZOLMITRIPTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CAT; CONTROLLED STUDY; DRUG EFFECT; EVOKED RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MIGRAINE; NERVE CELL INHIBITION; NONHUMAN; PRIORITY JOURNAL; TRIGEMINAL NUCLEUS;

EID: 0030272955     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(96)03118-1     Document Type: Article

References (34)

1. Bates, D., Ashford, E., Dawson, R., Ensink, F.-B.M., Gilhus, N.E., Olesen, J., Pilgrim, A.J. and Shevlin, P., Subcutaneous sumatriptan during the migraine aura, Neurology, 44 (1994) 1587-1592.
2. Buzzi, M.G., Moskowitz, M.A., Shimizu, T. and Heath, H.H., Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion, Neuropharmacology, 30 (1991) 1193-1200.
3. Dahlof, C., Diener, H.C., Goadsby, P.J., Massiou, H., Olesen, J., Schoenen, J., Wilkinson, M., Sweet, R.M. and Klein, K.B., A multicentre, double-blind, placebo-controlled, dose-range finding study to investigate the efficacy and safety of oral doses of 311C90 in the acute treatment of migraine, Headache, 35 (1995) 292.
4. Feindel, W., Penfield, W. and McNaughton, F., The tentorial nerves and localisation of intracranial pain in man, Neurology, 10 (1960) 555-563.
5. Ferrari, M.D., Treatment of migraine attacks with sumatriptan, N. Engl. J. Med., 325 (1991) 316-321.
6. Gallai, V., Sarchielli, P., Floridi, A., Franceschini, M., Codini, M., Trequattrini, A. and Palumbo, R., Vasoactive peptides levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally, Cephalalgia, 15 (1995) 384-390.
7. Goadsby, P.J., The challenge of headache for the nineties, Curr. Opin. Neurol., 7 (1994) 255-282.
8. Goadsby, P.J. and Duckworth, J.W., Effect of stimulation of trigeminal ganglion on regional cerebral blood flow in cats, Am. J. Physiol., 253 (1987) R270-R274.
9. Goadsby, P.J. and Edvinsson, L., The trigeminovascular system and migraine: studies characterising cerebrovascular and neuropeptide changes seen in man and cat, Ann. Neurol., 33 (1993) 48-56.
10. Goadsby, P.J. and Edvinsson, L., Human in vivo evidence for trigeminovascular activation in cluster headache, Brain, 117 (1994a) 427-434.
11. Goadsby, P.J. and Edvinsson, L., Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90, Headache, 34 (1994b) 394-399.
12. 3H]dihydroergotamine binding sites in the cat central nervous system: relevance to migraine, Ann. Neurol., 29 (1991) 91-94.
13. Goadsby, P.J. and Hoskin, K.L., Trigeminal neuronal activity is inhibited by intravenous administration of 311C90 in the cat, Cephalalgia, 15 (Suppl. 14) (1995) 106.
14. Goadsby, P.J., Edvinsson, L. and Ekman, R., Release of vasoactive peptides in the extracerebral circulation of man and the cat during activation of the trigeminovascular system, Ann. Neurol., 23 (1988) 193-196.
15. Goadsby, P.J., Edvinsson, L. and Ekman, R., Vasoactive peptide release in the extracerebral circulation of humans during migraine headache, Ann. Neurol., 28 (1990) 183-187.
16. Goadsby, P.J., Zagami, A.S. and Lambert, G.A., Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine, Headache, 31 (1991a) 365-371.
17. Goadsby, P.J., Zagami, A.S., Donnan, G.A., Symington, G., Anthony, M., Bladin, P.F. and Lance, J.W., A double blind placebo controlled crossover study of sumatriptan in the treatment of acute migraine attacks, Lancet, II (1991b) 782-783.
18. Hoskin, K.L., Kaube, H. and Goadsby, P.J., Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine: a c-Fos and electrophysiology study, Brain, 119 (1996) 249-256.
19. Humphrey, P.P.A. and Goadsby, P.J., Controversies in headache: the mode of action of sumatriptan is vascular? a debate, Cephalalgia, 14 (1994) 401-410.
20. Humphrey, P.P.A., Feniuk, W., Marriott, A.S., Tanner, R.J.N., Jackson, M.R. and Tucker, M.L., Preclinical studies on the anti-migraine drug, sumatriptan, Eur. Neurol., 31 (1991) 282-290.
21. Kaube, H., Hoskin, K.L. and Goadsby, P.J., Sumatriptan inhibits central trigeminal neurons only after blood-brain barrier disruption. Br. J. Pharmacol., 109 (1993) 788-792.
22. Keller, J.T., Saunders, M.C., Beduk, A. and Jollis, J.G., Innervation of the posterior fossa dura of the cat, Brain Res. Bull., 14 (1985) 97-102.
23. Lambert, G.A., Goadsby, P.J., Zagami, A.S. and Duckworth, J.W., Comparative effects of stimulation of the trigeminal ganglion and the superior sagittal sinus on cerebral blood flow and evoked potentials in the cat, Brain Res., 453 (1988) 143-149.
24. Lance, J.W., Mechanism and Management of Headache, 5th edn, Butterworth Scientific, London, 1993.
25. Martins, I.P., Baeta, E., Paiva, T., Campo, T. and Gomes, L., Headaches during intracranial endovascular procedures: a possible model of vascular headache, Headache, 33 (1993) 227-233.
26. McNaughton, F.L., The innervation of the intracranial blood vessels and the dural sinuses. In: S. Cobb, A.M. Frantz, W. Penfield and H.A. Riley (Eds.), The Circulation of the Brain and Spinal Cord, Hafner, New York, 1966, pp. 178-200.
27. Moskowitz, M.A. and Cutrer, F.M., Sumatriptan: a receptor-targeted treatment for migraine, Annu. Rev. Med., 44 (1993) 145-154.
28. Nichols, F.T., Mawad, M., Mohr, J.P., Hilal, S. and Adams, R.J., Focal headache during balloon inflation in the vertebral and basilar arteries, Headache, 33 (1993) 87-89.
29. O'Shaughnessy, C.T., Connor, H.E. and Feniuk, W., Extracellular recordings of membrane potential from guinea-pig isolated trigeminal ganglion: lack of effect of sumatriptan, Cephalalgia, 13 (1993) 175-179.
30. Ray, B.S. and Wolff, H.G., Experimental studies on headache: pain-sensitive structures of the head and their significance in headache, Arch. Surg., 41 (1940) 813-856.
31. Shepheard, S.L., Williamson, D.J., Williams, J., Hill, R.G. and Hargreaves, R.J., Comparison of the effects of sumatriptan and the NKI antagonist CP-99,994 on plasma extravasation in the dura mater and c-fos mRNA expression in the trigeminal nucleus caudalis of rats. Neuropharmacology, 34 (1995) 255-261.
32. Siegel, S., Non-Parametric statistics for the Behavioural Sciences, McGraw-Hill Kogakusha, Tokyo, 1956.
33. Wolff, H.G., Headache and Other Head Pain, Oxford University Press, New York, 1963 .
34. Zagami, A.S., Goadsby, P.J. and Edvinsson, L., Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides, Neuropeptides, 16 (1990) 69-75.